Watchlist Price Alert

Universe Pharmaceuticals ... (UPC)

NASDAQ: UPC · Real-Time Price · USD

3.71

-0.08 (-2.11%)

At close: Jun 27, 2025, 3:59 PM

3.77

1.52%

After-hours: Jun 27, 2025, 05:58 PM EDT

Universe Pharmaceuticals Income Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018
Period Ending	Sep 30, 2024	Mar 31, 2024	Sep 30, 2023	Mar 31, 2023	Sep 30, 2022	Mar 31, 2022	Sep 30, 2021	Mar 31, 2021	Sep 30, 2020	Mar 31, 2020	Sep 30, 2019	Mar 31, 2019	Sep 30, 2018	Mar 31, 2018
Revenue	23.02M	26.73M	32.31M	34.41M	40.14M	47.89M	47.98M	39.64M	30.7M	31.97M	24.92M	22.56M	21.39M	7.13M
Cost of Revenue	16.95M	19.42M	22.23M	20.34M	18.46M	20.99M	22.85M	20.73M	16.61M	18.22M	14.87M	12.51M	11.33M	3.78M
Gross Profit	6.07M	7.31M	10.08M	14.07M	21.69M	26.9M	25.14M	18.92M	14.09M	13.75M	10.06M	10.06M	10.06M	3.35M
Operating Income	-8.02M	-5.42M	-3.53M	-9.99M	-7.44M	6.71M	13.59M	14.76M	10.35M	10.05M	7.31M	7.27M	7.24M	2.41M
Interest Income	n/a	n/a	166.93K	166.93K	696.43K	935.98K	239.55K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-8.12M	-16.58M	-3.88M	-11.07M	-8.02M	7.43M	13.65M	14.58M	10.1M	9.88M	7.24M	7.17M	7.14M	2.38M
Net Income	-8.73M	-18.55M	-6.16M	-11.18M	-8.74M	5.9M	11.32M	10.93M	7.56M	7.55M	5.66M	5.69M	5.7M	1.9M
Selling & General & Admin	10.44M	9.91M	8.61M	14.13M	21.3M	14.68M	5.87M	3.31M	2.8M	2.92M	2.28M	2.24M	2.22M	740.8K
Research & Development	3.03M	2.65M	4.82M	9.73M	7.62M	5.28M	5.45M	593.5K	583.12K	600.78K	463.83K	549.3K	592.03K	197.34K
Other Expenses	616.27K	-168.19K	-179.19K	-196.94K	-205.58K	-224.62K	-223.98K	106.28K	365.77K	182.88K	n/a	n/a	n/a	n/a
Operating Expenses	14.09M	12.72M	13.6M	24.06M	29.12M	20.19M	11.54M	4.16M	3.74M	3.7M	2.74M	2.79M	2.81M	938.15K
Interest Expense	278.17K	218.83K	156.79K	148.58K	162.4K	143.32K	101.6K	108.55K	123.76K	126.51K	96.95K	114.78K	123.69K	41.23K
Selling & Marketing Expenses	7.26M	n/a	n/a	-20.25M	-20.25M	1.81M	1.81M	777.77K	1.56M	1.57M	1.18M	1.23M	1.26M	420.06K
Cost & Expenses	31.04M	32.14M	35.84M	44.4M	47.58M	41.18M	34.39M	24.89M	20.35M	21.92M	17.61M	15.3M	14.14M	4.71M
Income Tax Expense	606.7K	2M	2.31M	148.56K	752.42K	1.53M	2.36M	3.68M	2.54M	2.32M	1.58M	1.48M	1.44M	478.78K
Shares Outstanding (Basic)	607.66K	607.66K	604.17K	604.17K	604.17K	604.17K	604.17K	604.17K	583.33K	583.33K	583.33K	583.33K	583.33K	583.33K
Shares Outstanding (Diluted)	607.66K	607.66K	604.17K	604.17K	604.17K	604.17K	604.17K	604.17K	583.33K	583.33K	583.33K	583.33K	583.33K	583.33K
EPS (Basic)	-2.39	-5.09	-1.7	-3.09	-2.41	1.63	3.12	2.15	0.36	0.36	0.27	0.27	0.27	0.09
EPS (Diluted)	-2.39	-5.09	-1.7	-3.09	-2.41	1.63	3.12	2.15	0.36	0.36	0.27	0.27	0.27	0.09
EBITDA	-7.36M	-15.86M	-3.22M	-10.43M	-7.33M	8.07M	14.2M	15.14M	10.63M	10.42M	7.65M	7.62M	7.6M	2.53M
EBIT	-7.84M	-16.36M	-3.72M	-10.93M	-7.86M	7.57M	13.75M	14.69M	10.22M	10M	7.34M	7.29M	7.26M	2.42M
Depreciation & Amortization	485.73K	499.87K	508.79K	499.62K	533.95K	495.52K	446.88K	448.5K	410.08K	414.25K	313.82K	330.97K	339.55K	113.18K